Yasemin Fatma ÇETİNKAYA, Ceren KARAÇAYLI

Yatırılarak tedavi edilen COVID-19 hastalarinda göz bulguları

Amaç: Tüm dünyayı etkisi altına alan COVID-19 hastalığı, sağlık sistemini ciddi anlamda zora sokmuştur. Sağlık hizmetlerinin sunumunun tehlikede olduğu bu dönemde, hastalığın insan vücudunun farklı bölgelerini nasıl etkilediğinin anlaşılması geri planda kalmıştır. Bu çalışma, yatarak tedavi gören COVID-19 hastalarından oküler şikayetleri ve bulguları olan hastaları belirlemek amacıyla yapılmıştır. Yöntem: 25 Mart 2020 ile 31 Mart 2021 tarihleri arasında üçüncü basamak bir hastanede COVID-19 nedeniyle takip ve tedavi edilen 18 yaş ve üzeri bireylerde kesitsel, geriye dönük bir çalışma yapılmıştır. Tüm hastaların elektronik sağlık kayıtları alınarak gözden geçirilmiştir. Ayrıca oküler semptomları olan ve olmayan hastalar arasında prokalsitonin, üre seviyesi ve nötrofil sayısı karşılaştırılmıştır. Bulgular: Çalışmamıza COVID-19 testi pozitif olan toplam 7,060 hasta dahil edildi. Ortalama hasta yaşı 60,89±16,96 idi. Hastaların %52,8 (n=19)’i kadın, %47,2 (n=17)’si erkekti. Oftalmoloji konsültasyon oranı toplam 36 hasta ile %0.5 idi. Hastaların %47.2 (n=17)’sinde en sık görülen semptom görme değişiklikleri idi. En sık görülen ikinci oküler patoloji kemozdu, bunu konjonktival hiperemi ve göz irritasyonu izledi. Keratopatiye maruz kalan hastaların %100’ünde yoğun bakım öyküsü vardı (p

Ocular findings in patients hospitalized for COVID-19

Objective: The COVID-19 disease, which has affected the whole world, has seriously challenged the health system. In this period when the delivery of health services is in danger, understanding how the disease affects different parts of the human body has remained in the background. This study was conducted to identify patients with ocular complaints and findings from inpatient COVID-19 patients. Methods: A cross-sectional, retrospective study was conducted in individuals aged 18 years and older who were followed up and treated for COVID-19 in a tertiary hospital between 25 March 2020 and 31 March 2021. Electronic health records of all patients were reviewed. In adition Procalcitonin, urea, and neutrophil levels were compared between patients with and without ocular symptoms. Results: A total of 7060 patients with positive COVID-19 tests were included in our study. The mean patient age was 60.89±16.96 years. 52.8% (n=19) of the patients were female and 47.2% (n=17) were male. The ophthalmology consultation rate was 0.5% with a total of 36 patients. The most common symptom was visual changes in 47.2% (n=17) of the patients. The second most common ocular pathology was chemosis, followed by conjunctival hyperemia and eye irritation. 100% of the patients exposed to keratopathy had a history of intensive care. (p

PDF

___

1. Zhou P, Yang XL, Wang XG, Hu B,Zhang L,Zhang W,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nat . 2020;579(7798):270-3.
2. Petersen E, Hui D, Hamer DH, Blumberg L,Madoff LC,Pollack M, et al. Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak.Int J Infect Dis. 2020;93:205-7.
3. Hui KPY, Cheung MC, Perera R APM,Ng KC,Bui C HT,Ho J CW H.,et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020;8(7):687-95.
4. World Health Organization. Coronavirus disease (COVID-19) pandemic.2020.
5. Bozkurt B, Eğrilmez S, Şengör T, Yıldırım Ö,İrkeç M. COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme Türk Oftalmoloji Dergisi. 2020;50(2):59-63.
6. Cheema M, Aghazadeh H, Nazarali S,Ting A,Hodges J,McFarlane A, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020;55(4):e125-e129.
7. Loffredo L, Pacella F, Pacella E, Tiscione G, Oliva A, Violi F. Conjunctivitis and COVID 19: A meta analysis. J Med Virol. 2020;92(9):1413-4.
8. Sindhuja K, Lomi N, Asif M, Tandon R. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study. Indian J Ophthalmol. 2020;68(8):1546.
9. Sitaula RK, Khatri A, Janani MK, Mandage R,Sadhu S, Madhavan HN,et al. Unfolding COVID-19: Lessons-in-Learning in Ophthalmology. Clin Ophthalmol. 2020;Volume 14:2807-20.
10. Sadhu S, Agrawal R, Pyare R,Pavesio C,Zierhut M, Khatri A,et al. COVID-19: Limiting the Risks for Eye Care Professionals. Ocul Immunol Inflamm. 2020;28(5):714-20.
11. Wu P, Duan F, Luo C,Liu Q,Qu X,Liang L, et al. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575-8.
12. Limbu B, Khatri A, Joshi P, Lamichhane G,Manandhar A,Pradhan K, et al. COVID-19 preferred practice pattern for eye care professional - An initiative by Nepal Ophthalmic Society. Nepal J Ophthalmol. 2020;12(2):176-90.
13. Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R. Retinal findings in patients with COVID-19. Lancet. 2020;395(10237):1610.
14. Lu C, Liu X, Jia Z. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395(10224):e39.
15. Sawant OB, Singh S, Wright RE,Jones KM,Titus MS,Dennis E, et al. Prevalence of SARS-CoV-2 in human post-mortem ocular tissues. Ocul Surf. 2021;19:322-9.
16. Zimmerman K, Kearns F, Tzekov R. Natural protection of ocular surface from viral infections – A hypothesis. Med Hypotheses. 2020;143:110082.
17. Feng Y, Armenti ST, Mian SI. COVID-19 and the Eye: A Comprehensive Review of the Literature. Int Ophthalmol Clin. 2021;61(1):1-14.
18. Chen L, Deng C, Chen X,Zhang X,Chen B,Yu H, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID 19 in Wuhan, China: a cross sectional study. Acta Ophthalmol. 2020;98(8):e951-e959.
19. Seah IYJ, Anderson DE, Kang AEZ, Whang L,Rao P,Young BE, et al. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients. Ophthalmology. 2020;127(7):977-979.
20. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020 267. 2020;26(7):1017-1032.